Pinned Tweet
#ASHP26 registration is now open! Our Midyear Clinical Meeting & Exhibition is filled with possibilities - join your peers at the must-attend pharmacy event of the year to share knowledge and insight, discuss new ideas, and make connections that will help advance your career and practice: hubs.ly/Q04p_W_r0
3
1,235
ASHP thanks @JohnMannionNY22 for cosponsoring the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
ASHP thanks @AustinScottGA08 for cosponsoring the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
757
In this podcast episode, ASHP Executive Vice President and CEO Sam Calabrese joins Tom Kraus, ASHP chief advocacy officer, to discuss how the recent midterm election could influence healthcare policy and what pharmacy professionals should watch in the months ahead. Listen and download here: hubs.ly/Q04Fg9S00
327
.@AP reports, “Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug.” apnews.com/article/ibogaine-…
572
ASHP thanks @RepYvetteClarke for cosponsoring the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
547
ASHP thanks @RepDonDavis for cosponsoring the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
833
As residency application season approaches, the Sections of Community Pharmacy Practitioners and Specialty Pharmacy Practitioners are planning informational sessions for pharmacy students to hear directly from current residents. Two upcoming sessions are planned, one with community-based residents and one with residents completing residency within specialty pharmacies. Registration is open now!
Community-Based Residencies - Q&A with Current Residents: hubs.ly/Q04F1rbT0
Health-System Specialty Pharmacy: Residencies and Careers: hubs.ly/Q04F1rKf0
1
456
ASHP thanks @RepMikeLawler for cosponsoring the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
527
ASHP thanks @RepRitchie for cosponsoring the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
571
The incretin story keeps evolving. What should pharmacists know about the latest indications and breakthroughs? Dianna Isaacs and Christie Schumacher join the ASHP Midyear Speaker Series to preview “The Incredible Incretins: Expanded Indications and the Latest Breakthroughs.” Listen now for a taste of what’s coming at #ASHP26, then register for Midyear to attend the full session: hubs.ly/Q04F73b-0
369
This podcast episode discusses the Centers for Medicare and Medicaid Services (CMS) Physician Fee Schedule (PFS) proposed rule, with a focus on the proposals that are most relevant to our members. We discuss CMS’s request for information regarding redesigning primary care, as well as other proposals, including changes to modifier 25, remote monitoring, and remote therapeutic services. Listen to the episode here: hubs.ly/Q04F6-y20
346
ASHP thanks @RepBresnahan (R-PA), @RepDebDingell (D-MI), @RepMann (R-KS), and @RepLoisFrankel (D-FL) for introducing the 340B Rebate Model Delay Act (H.R. 10770). This bill will halt pharmaceutical manufacturers from inappropriately delaying 340B payments to safety-net hospitals and clinics that rely on access to discounted medications to provide critical patient care. congress.gov/bill/119th-cong…
1
812
.@washingtonpost reports, “Women seeking estrogen patches for relief from menopause symptoms have been stymied by a months-long, nationwide shortage that has expanded to include other forms of hormone therapy.” washingtonpost.com/health/20…
New on-demand ASHP Advantage webinar: “Hurry, Time is Wasting: The Pharmacy Workforce and the Cost-Effectiveness and Safety of Ready to Administer Products.” This 1.5-hour educational activity reviews the evidence for the safety and cost-effectiveness of ready-to-administer (RTA) prefilled syringes compared to the traditional vial-and-syringe method and discusses real-world aspects of transitioning from traditional to RTA products. This activity offers CPEL Recertification Credit. Learn more and register: hubs.ly/Q04F1hXJ0
1
416
ASHP is seeking applicants for the Executive Fellowship in Association Leadership and Management, a unique opportunity to gain hands-on experience across all aspects of not-for-profit association leadership and management. Fellows work closely with senior pharmacy leaders, developing their leadership, communication, strategic thinking, and problem-solving skills while contributing to initiatives that advance pharmacy practice and patient care.
Attending Midyear? Visit us to learn more!
💠Residency showcase (booth 6653) on Tuesday, Dec. 8 from 1 to 4 p.m. ET: hubs.ly/Q04F1dBj0
💠Schedule a PPS interview with us: hubs.ly/Q04F19-p0
💠Fellowship Open House (booth 7524) on Saturday, Dec. 5 from 4:30 to 5:30 p.m. ET (PPS Hall): hubs.ly/Q04F19-n0
Learn more and apply: hubs.ly/Q04F19-m0
1
484
ASHP has two new podcasts showcasing military service’s impact on our members’ careers.
First up, three pharmacists join U.S. Army Col. Sherry Kwon to discuss how military service shaped their professional decisions and leadership philosophies: hubs.ly/Q04F18kd0
To hear from members who care for veterans, check out our second podcast for practical guidance on professional development and team building from the Department of Veterans Affairs pharmacy leaders: hubs.ly/Q04F18By0
ASHP is proud of our members who have served. Happy #VeteransDay!
From cell and gene therapies to pharmacogenomics, the next generation of therapeutics is already transforming patient care. Heidi Trinkman and Emilie Aschenbrenner join the ASHP Midyear Speaker Series to preview their #ASHP26 session, “Transforming Care Through Next-Generation Therapeutics: Theranostics, Cell and Gene Therapies, and Pharmacogenomics.” Get a preview of the conversation, then register for Midyear to learn more in Orlando: hubs.ly/Q04DXCr50
399
Although ketamine was initially used as a general anesthetic, it has since emerged as a valuable option for managing both acute and chronic pain. This CE podcast episode explores the role of intravenous ketamine across the perioperative setting, emergency medicine, and palliative care. Listen and download: hubs.ly/Q04DXgrq0
1
414
.@washingtonpost reports that the FDA “announced Monday that it is requiring manufacturers of GLP-1 medications to warn that they can increase the risk of” a condition that can lead to vision loss. This “warning applies to all GLP-1 medications.” washingtonpost.com/health/20…
467










